These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22699685)

  • 1. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder.
    Telford C; Green C; Logan S; Langley K; Thapar A; Ford T
    Soc Psychiatry Psychiatr Epidemiol; 2013 Feb; 48(2):337-44. PubMed ID: 22699685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.
    Quintero J; Ramos-Quiroga JA; Sebastián JS; Montañés F; Fernández-Jaén A; Martínez-Raga J; Giral MG; Graell M; Mardomingo MJ; Soutullo C; Eiris J; Téllez M; Pamias M; Correas J; Sabaté J; García-Orti L; Alda JA
    BMC Psychiatry; 2018 Feb; 18(1):40. PubMed ID: 29422022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.
    Lachaine J; De G; Sikirica V; Van Stralen J; Hodgkins P; Yang H; Heroux J; Ben Amor L
    Can J Psychiatry; 2014 Nov; 59(11):597-608. PubMed ID: 25565476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
    Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA
    Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.
    Burd L; Klug MG; Coumbe MJ; Kerbeshian J
    J Child Neurol; 2003 Aug; 18(8):555-61. PubMed ID: 13677583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Cloutier M; Guérin A; Lefebvre P
    J Manag Care Spec Pharm; 2022 Feb; 28(2):168-179. PubMed ID: 34806909
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource use and service costs for ventilator-dependent children and young people in the UK.
    Noyes J; Godfrey C; Beecham J
    Health Soc Care Community; 2006 Nov; 14(6):508-22. PubMed ID: 17059493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
    Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
    BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.
    Jennum P; Hastrup LH; Ibsen R; Kjellberg J; Simonsen E
    Eur Neuropsychopharmacol; 2020 Aug; 37():29-38. PubMed ID: 32682821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.
    Le HH; Hodgkins P; Postma MJ; Kahle J; Sikirica V; Setyawan J; Erder MH; Doshi JA
    Eur Child Adolesc Psychiatry; 2014 Jul; 23(7):587-98. PubMed ID: 24166532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium.
    De Ridder A; De Graeve D
    Clin Drug Investig; 2006; 26(2):75-90. PubMed ID: 17163238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).
    Hakkaart-van Roijen L; Zwirs BW; Bouwmans C; Tan SS; Schulpen TW; Vlasveld L; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):316-26. PubMed ID: 17483870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.